Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Straumann

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
United European Gastroenterology Journal|April 12, 2022
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 ProgrammeStephan Miehlke, Christoph Schlag, Alfredo J Lucendo, et al.
Alimentary Pharmacology & Therapeutics|December 16, 2024
Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic OesophagitisAlfredo J Lucendo, Óscar Nantes-Castillejo, Alex Straumann, et al.
Gastroenterology|March 30, 2019
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled TrialAlfredo J Lucendo, Stephan Miehlke, Christoph Schlag, et al.
Gut|March 21, 2015
A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitisStephan Miehlke, Petr Hruz, Michael Vieth, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2022
Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert RecommendationsUlrike von Arnim, Luc Biedermann, Seema S Aceves, et al.
Allergy|January 30, 2022
Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross-sectional multi-center studyThomas Greuter, Alex Straumann, Yuniel Fernandez-Marrero, et al.
Gastroenterology|July 30, 2020
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic EsophagitisAlex Straumann, Alfredo J Lucendo, Stephan Miehlke, et al.
Allergy|July 15, 2020
Food-induced immediate response of the esophagus-A newly identified syndrome in patients with eosinophilic esophagitisLuc Biedermann, Mark Holbreich, Dan Atkins, et al.
Clinical and Translational Gastroenterology|February 6, 2024
A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over TimeThomas Greuter, Alex Straumann, Yuniel Fernandez-Marrero, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension StudyLuc Biedermann, Christoph Schlag, Alex Straumann, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
United European Gastroenterology Journal|April 12, 2022
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 ProgrammeStephan Miehlke, Christoph Schlag, Alfredo J Lucendo, et al.
Alimentary Pharmacology & Therapeutics|December 16, 2024
Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic OesophagitisAlfredo J Lucendo, Óscar Nantes-Castillejo, Alex Straumann, et al.
Gastroenterology|March 30, 2019
Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled TrialAlfredo J Lucendo, Stephan Miehlke, Christoph Schlag, et al.
Gut|March 21, 2015
A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitisStephan Miehlke, Petr Hruz, Michael Vieth, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2022
Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert RecommendationsUlrike von Arnim, Luc Biedermann, Seema S Aceves, et al.
Allergy|January 30, 2022
Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross-sectional multi-center studyThomas Greuter, Alex Straumann, Yuniel Fernandez-Marrero, et al.
Gastroenterology|July 30, 2020
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic EsophagitisAlex Straumann, Alfredo J Lucendo, Stephan Miehlke, et al.
Allergy|July 15, 2020
Food-induced immediate response of the esophagus-A newly identified syndrome in patients with eosinophilic esophagitisLuc Biedermann, Mark Holbreich, Dan Atkins, et al.
Clinical and Translational Gastroenterology|February 6, 2024
A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over TimeThomas Greuter, Alex Straumann, Yuniel Fernandez-Marrero, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension StudyLuc Biedermann, Christoph Schlag, Alex Straumann, et al.
Pageof 18